Coping With Stress: The Mitokine GDF-15 as a Biomarker of COVID-19 Severity.
Saved in:
| Title: | Coping With Stress: The Mitokine GDF-15 as a Biomarker of COVID-19 Severity. |
|---|---|
| Authors: | Ahmed DS; Infectious Disease and Immunity in Global Health Program, Research Institute of McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada., Isnard S; Infectious Disease and Immunity in Global Health Program, Research Institute of McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.; CIHR Canadian HIV Trials Network, Vancouver, BC, Canada., Berini C; Infectious Disease and Immunity in Global Health Program, Research Institute of McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.; CONICET - Universidad de Buenos Aires, Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), Buenos Aires, Argentina., Lin J; Infectious Disease and Immunity in Global Health Program, Research Institute of McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada., Routy JP; Infectious Disease and Immunity in Global Health Program, Research Institute of McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.; CONICET - Universidad de Buenos Aires, Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), Buenos Aires, Argentina., Royston L; Infectious Disease and Immunity in Global Health Program, Research Institute of McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.; CIHR Canadian HIV Trials Network, Vancouver, BC, Canada.; Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland. |
| Source: | Frontiers in immunology [Front Immunol] 2022 Feb 16; Vol. 13, pp. 820350. Date of Electronic Publication: 2022 Feb 16 (Print Publication: 2022). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35251002 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Coping With Stress: The Mitokine GDF-15 as a Biomarker of COVID-19 Severity. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ahmed+DS%22">Ahmed DS</searchLink>; Infectious Disease and Immunity in Global Health Program, Research Institute of McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Isnard+S%22">Isnard S</searchLink>; Infectious Disease and Immunity in Global Health Program, Research Institute of McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.; CIHR Canadian HIV Trials Network, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Berini+C%22">Berini C</searchLink>; Infectious Disease and Immunity in Global Health Program, Research Institute of McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.; CONICET - Universidad de Buenos Aires, Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), Buenos Aires, Argentina.<br /><searchLink fieldCode="AU" term="%22Lin+J%22">Lin J</searchLink>; Infectious Disease and Immunity in Global Health Program, Research Institute of McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Routy+JP%22">Routy JP</searchLink>; Infectious Disease and Immunity in Global Health Program, Research Institute of McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.; CONICET - Universidad de Buenos Aires, Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), Buenos Aires, Argentina.<br /><searchLink fieldCode="AU" term="%22Royston+L%22">Royston L</searchLink>; Infectious Disease and Immunity in Global Health Program, Research Institute of McGill University Health Centre, Montreal, QC, Canada.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada.; CIHR Canadian HIV Trials Network, Vancouver, BC, Canada.; Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2022 Feb 16; Vol. 13, pp. 820350. <i>Date of Electronic Publication: </i>2022 Feb 16 (<i>Print Publication: </i>2022). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35251002 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2022.820350 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 820350 Titles: – TitleFull: Coping With Stress: The Mitokine GDF-15 as a Biomarker of COVID-19 Severity. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ahmed DS – PersonEntity: Name: NameFull: Isnard S – PersonEntity: Name: NameFull: Berini C – PersonEntity: Name: NameFull: Lin J – PersonEntity: Name: NameFull: Routy JP – PersonEntity: Name: NameFull: Royston L IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 02 Text: 2022 Feb 16 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 13 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |